Cardiogen 25 mg vial
- Ion Peptides$59Listed price · deal not verifiedCOA tested Sep 5, 2026
Cardiogen is a short-peptide product commonly placed in the bioregulator category.
Also known as cardiogen
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
1 of 2 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: Cardiogen COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $1.98 | $2.75 | 10 | 10 | |
| $1.98 | $2.75 | 11 | 11 | |
| $1.98 | $2.76 | 10 | 10 | |
| $0.18 | $2.23 | 5 | 8 |
What it is
(R)-carnitine is the (R)-enantiomer of carnitine. It has a role as a water-soluble vitamin (role), an antilipemic drug, a nutraceutical, a nootropic agent and a Saccharomyces cerevisiae metabolite. It is a conjugate base of a (R)-carnitinium. It is an enantiomer of a (S)-carnitine. The listed molecular formula is C7H15NO3. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
4 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
Cardiogen is commonly sold or discussed for organ-specific bioregulator research and general wellness goals. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Bulk Peptide Supply | Grade B+ | 1 | 1 | $32.50 · 20 mg vialObserved Nov 14, 2026 |
| Peptide Crafters | Grade B+ | 1 | 1 | $55 · 25 mg vialEarlier observation Nov 1, 2026 |
| Core Peptides | Grade B+ | 1 | 1 | $75 · 20 mg vialEarlier observation Oct 20, 2026 |
| Biolongevity Labs | Grade B | 1 | 0 | $69.97 · 20 mg vialObserved Nov 14, 2026 · out of stock |
| Ion Peptides | Grade B | 1 | 1 | $59 · 25 mg vialObserved Nov 14, 2026 |
| Paramount Peptides | Grade B | 1 | 1 | $80 · 20 mg vialObserved Nov 14, 2026 |
| Swiss Chems | Grade C | 1 | 1 | $63.95 · 20 mg vialObserved Nov 14, 2026 |
| Nuscience Peptides | Not graded | 1 | 1 | $59.99 · 20 mg vialObserved Nov 14, 2026 |
4 tracked vendors list Cardiogen without a current offer: Nationwide Peptides (Grade B+), Mile High Compounds (Grade B), Peptidology (Grade C), Atomik Labz (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.